{"id":17034,"date":"2022-04-15T15:47:37","date_gmt":"2022-04-15T10:17:37","guid":{"rendered":"https:\/\/www.delveinsight.com\/blog\/?p=17034"},"modified":"2025-10-09T17:02:08","modified_gmt":"2025-10-09T11:32:08","slug":"glaucoma-drainage-devices-market","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/glaucoma-drainage-devices-market","title":{"rendered":"Prominent Players in Glaucoma Drainage Devices Market"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_76 counter-hierarchy ez-toc-counter ez-toc-white ez-toc-container-direction\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<label for=\"ez-toc-cssicon-toggle-item-69e867000c943\" class=\"ez-toc-cssicon-toggle-label\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/label><input type=\"checkbox\"  id=\"ez-toc-cssicon-toggle-item-69e867000c943\"  aria-label=\"Toggle\" \/><nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.delveinsight.com\/blog\/glaucoma-drainage-devices-market\/#Glaucoma_Drainage_Devices_its_Types\" >Glaucoma Drainage Devices &amp; its Types<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.delveinsight.com\/blog\/glaucoma-drainage-devices-market\/#EX-PRESS%C2%AE_Trabeculectomy-modifying_device\" >EX-PRESS\u00ae (Trabeculectomy-modifying device)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.delveinsight.com\/blog\/glaucoma-drainage-devices-market\/#Minimally_invasive_glaucoma_surgery_MIGS_devices\" >Minimally invasive glaucoma surgery (MIGS) devices<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/www.delveinsight.com\/blog\/glaucoma-drainage-devices-market\/#Key_Five_Players_in_the_Glaucoma_Drainage_Devices_Market\" >Key Five Players in the Glaucoma Drainage Devices Market<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/www.delveinsight.com\/blog\/glaucoma-drainage-devices-market\/#Johnson_Johnson_Services_Inc_%E2%80%93_New_Jersey_United_States\" >Johnson &amp; Johnson Services, Inc. \u2013 New Jersey, United States<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/www.delveinsight.com\/blog\/glaucoma-drainage-devices-market\/#Alcon_Inc_-_Illinois_United_States\" >Alcon Inc - Illinois, United States<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/www.delveinsight.com\/blog\/glaucoma-drainage-devices-market\/#Glaukos_Corporation_-_California_United_States\" >Glaukos Corporation - California, United States<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/www.delveinsight.com\/blog\/glaucoma-drainage-devices-market\/#AbbVie_Inc_-_Illinois_United_States\" >AbbVie Inc. - Illinois, United States<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/www.delveinsight.com\/blog\/glaucoma-drainage-devices-market\/#Santen_Pharmaceutical_Co_Ltd_%E2%80%93_Osaka_Japan\" >Santen Pharmaceutical Co., Ltd \u2013 Osaka, Japan<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/www.delveinsight.com\/blog\/glaucoma-drainage-devices-market\/#Recent_Developments_in_the_Glaucoma_Drainage_Devices_Market\" >Recent Developments in the Glaucoma Drainage Devices Market<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/www.delveinsight.com\/blog\/glaucoma-drainage-devices-market\/#Conclusion\" >Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/www.delveinsight.com\/blog\/glaucoma-drainage-devices-market\/#FAQs\" >FAQs<\/a><\/li><\/ul><\/nav><\/div>\n\n<p>Glaucoma is a group of progressive optic neuropathy which is characterized by the degradation of ganglion cells present in the retina. The loss of the retinal ganglion is associated with intraocular pressure (IOP), an elevated IOP due to an imbalance in the production and drainage of aqueous humor that might lead to structural changes in the lamina cribrosa (a mesh-like structure at the optic nerve head that surrounds and supports the retinal ganglion cell axons as they form the optic nerve). This further causes impairment in the signal transmission by the axons through the optic nerve fibers leading to progressive damage in the visual field. Apart from increased IOP, low perfusion pressure, and\/or low cerebrospinal fluid pressure also raise the gradient across the lamina cribrosa and damage the vision. Glaucoma is one of the leading causes of irreversible vision loss across the globe. The Glaucoma diagnosis is frequently delayed because it might be asymptomatic until the late stage.<\/p>\n\n\n\n<p>Different <a href=\"https:\/\/www.delveinsight.com\/report-store\/glaucoma-market\">types of glaucoma<\/a> are categorized based on respective structural changes in the anterior segment of the eye. The two major types of glaucoma are <a href=\"https:\/\/www.delveinsight.com\/report-store\/open-angle-glaucoma-oag-market\">Open-angle glaucoma<\/a> and Angle-closure glaucoma (also referred to as \u201cclosed-angle glaucoma\u201d or \u201cnarrow-angle glaucoma\u201d). The other complicated glaucomas are uveitic glaucoma, neovascular glaucoma, and pediatric and developmental glaucomas, among others. The disease is treated by lowering the eye pressure (intraocular pressure). Depending on the situation, the options for Glaucoma treatment comprise <strong>prescription eye drops, oral medications, laser treatment for glaucoma, surgery, or a combination of any of these<\/strong>.<\/p>\n\n\n\n<p>When the <a href=\"https:\/\/www.delveinsight.com\/report-store\/glaucoma-pipeline-insight\">Glaucoma medicines<\/a> and eye drops could not improve the condition, Glaucoma surgery is recommended. There are different surgeries which include <strong>conventional filtration surgeries such as trabeculectomy, glaucoma implant surgery<\/strong>, and recently emerged <strong>minimally invasive glaucoma surgery (MIGS)<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-glaucoma-drainage-devices-amp-its-types\"><span class=\"ez-toc-section\" id=\"Glaucoma_Drainage_Devices_its_Types\"><\/span><strong>Glaucoma Drainage Devices &amp; its Types<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Glaucoma drainage devices used in glaucoma surgery are designed to reduce intraocular pressure (IOP) by diverting the aqueous humor to an external reservoir from the anterior chamber. Several of the currently available glaucoma drainage devices in the market include conventional aqueous shunts (tube-plate design) and more recent implants, such as the <strong>EX-PRESS\u00ae Glaucoma Filtration Device<\/strong> and the new <strong>MIGS devices<\/strong>.<\/p>\n\n\n\n<p><strong>Conventional Glaucoma Drainage Devices<\/strong><\/p>\n\n\n\n<p>Conventional glaucoma implants are the traditional aqueous shunts that drain the aqueous humor with the help of a tube inserted into the anterior chamber to a sub-Tenon\u2019s endplate by creating a more posteriorly located bleb. Depending on the presence of a valve mechanism, these implants are categorized into two types valved (flow-restricted) or non-valved devices.<\/p>\n\n\n\n<p><strong>Valved implants <\/strong>allow only unidirectional flow from the anterior chamber to the subconjunctival space with a minimum opening pressure whereas non-valved devices drain aqueous humor from the anterior chamber through an open, unobstructed tube. Some of the commercially available aqueous shunts include the <strong>Molteno\u00ae (NOAEYE Medical), Baerveldt\u00ae (Johnson &amp; Johnson Vision), PAUL\u00ae implants (Advanced Ophthalmic Innovations), Ahmed\u00ae Glaucoma Valve (New World Medical), and Ahmed\u00ae ClearPath (New World Medical)<\/strong>.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-ex-press-trabeculectomy-modifying-device\"><span class=\"ez-toc-section\" id=\"EX-PRESS%C2%AE_Trabeculectomy-modifying_device\"><\/span><strong>EX-PRESS\u00ae (Trabeculectomy-modifying device)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>EX-PRESS\u00ae was designed to offer a safe and simple alternative to the classic trabeculectomy. This glaucoma filtration device is a miniature, tube-like implant made of medical-grade stainless steel. The glaucoma surgery with the EX-PRESS device lowered the IOP similar to that of trabeculectomy.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-minimally-invasive-glaucoma-surgery-migs-devices\"><span class=\"ez-toc-section\" id=\"Minimally_invasive_glaucoma_surgery_MIGS_devices\"><\/span><strong>Minimally invasive glaucoma surgery (MIGS) devices<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>According to the <strong>Food and Drug Administration (FDA)<\/strong>, MIGS devices are defined as \u201ca type of IOP-lowering device used to lower IOP using an outflow mechanism with either an ab interno or ab externo approach, associated with little or no scleral dissection and minimal or no conjunctival manipulation\u201d. Whereas, as per the <strong>European Glaucoma Society Guidelines<\/strong>, only the ab interno non-bleb-forming procedures can be defined as MIGS.<\/p>\n\n\n\n<p>Based on the site of anatomical intervention and augmentation MIGS devices are sub-classified into three main categories: <strong>schlemm\u2019s canal MIGS devices, suprachoroidal MIGS devices, and subconjunctival MIGS devices.<\/strong><\/p>\n\n\n\n<p><strong>Factors Strengthening the Glaucoma Drainage Devices Market<\/strong>The growing burden of glaucoma across the globe is the predominant factor responsible for an increased demand for glaucoma drainage devices, worldwide. For instance, according to the <strong>World Glaucoma Association 2022<\/strong>, globally, an estimated <strong>80 million<\/strong> people were suffering from glaucoma in the year 2020. Additionally, the source also projected the number to increase to <strong>111.8 million<\/strong> individuals in 2040. Furthermore, as per <strong>DelveInsight <\/strong><a href=\"https:\/\/www.delveinsight.com\/report-store\/glaucoma-epidemiology-forecast-insight\"><strong>Glaucoma Epidemiology Forecast Report<\/strong><\/a>, the total diagnosed prevalent population of Glaucoma in the 7MM was more than <strong>10 million<\/strong> in 2020,  which is expected to increase in the forecast period. Among the 7MM, the US accounted the majority of the Glaucoma diagnosed prevalent cases in 2020.<\/p>\n\n\n\n<div contenteditable=\"false\"><div id=\"highcharts-632814c1-f355-43e0-9495-0fe28c044ef9\"><svg aria-hidden=\"false\" aria-label=\"Interactive chart\" class=\"highcharts-root\" height=\"400\" style=\"font-family: &quot;Lucida Grande&quot;, &quot;Lucida Sans Unicode&quot;, Arial, Helvetica, sans-serif; font-size: 12px;\" version=\"1.1\" viewBox=\"0 0 509 400\" width=\"509\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\"><desc aria-hidden=\"true\">Created with Highcharts 10.0.0<\/desc><defs aria-hidden=\"true\"><clipPath id=\"highcharts-p5dnaau-496-\"><rect fill=\"none\" height=\"233\" width=\"460\" x=\"0\" y=\"0\"><\/rect><\/clipPath><clipPath id=\"highcharts-p5dnaau-501-\"><rect fill=\"none\" height=\"233\" width=\"460\" x=\"0\" y=\"0\"><\/rect><\/clipPath><clipPath id=\"highcharts-p5dnaau-502-\"><rect fill=\"none\" height=\"233\" width=\"460\" x=\"39\" y=\"92\"><\/rect><\/clipPath><\/defs><rect aria-hidden=\"true\" class=\"highcharts-background\" fill=\"#ffffff\" height=\"400\" rx=\"0\" ry=\"0\" width=\"509\" x=\"0\" y=\"0\"><\/rect><rect aria-hidden=\"true\" class=\"highcharts-plot-background\" fill=\"none\" height=\"233\" width=\"460\" x=\"39\" y=\"92\"><\/rect><g aria-hidden=\"true\" class=\"highcharts-pane-group\" data-z-index=\"0\"><\/g><g aria-hidden=\"true\" class=\"highcharts-grid highcharts-xaxis-grid\" data-z-index=\"1\"><path class=\"highcharts-grid-line\" d=\"M 153.5 92 L 153.5 325\" data-z-index=\"1\" fill=\"none\" opacity=\"1\" stroke-dasharray=\"none\"><\/path><path class=\"highcharts-grid-line\" d=\"M 268.5 92 L 268.5 325\" data-z-index=\"1\" fill=\"none\" opacity=\"1\" stroke-dasharray=\"none\"><\/path><path class=\"highcharts-grid-line\" d=\"M 383.5 92 L 383.5 325\" data-z-index=\"1\" fill=\"none\" opacity=\"1\" stroke-dasharray=\"none\"><\/path><path class=\"highcharts-grid-line\" d=\"M 498.5 92 L 498.5 325\" data-z-index=\"1\" fill=\"none\" opacity=\"1\" stroke-dasharray=\"none\"><\/path><path class=\"highcharts-grid-line\" d=\"M 38.5 92 L 38.5 325\" data-z-index=\"1\" fill=\"none\" opacity=\"1\" stroke-dasharray=\"none\"><\/path><\/g><g aria-hidden=\"true\" class=\"highcharts-grid highcharts-yaxis-grid\" data-z-index=\"1\"><path class=\"highcharts-grid-line\" d=\"M 39 325.5 L 499 325.5\" data-z-index=\"1\" fill=\"none\" opacity=\"1\" stroke=\"#e6e6e6\" stroke-dasharray=\"none\" stroke-width=\"1\"><\/path><path class=\"highcharts-grid-line\" d=\"M 39 286.5 L 499 286.5\" data-z-index=\"1\" fill=\"none\" opacity=\"1\" stroke=\"#e6e6e6\" stroke-dasharray=\"none\" stroke-width=\"1\"><\/path><path class=\"highcharts-grid-line\" d=\"M 39 247.5 L 499 247.5\" data-z-index=\"1\" fill=\"none\" opacity=\"1\" stroke=\"#e6e6e6\" stroke-dasharray=\"none\" stroke-width=\"1\"><\/path><path class=\"highcharts-grid-line\" d=\"M 39 209.5 L 499 209.5\" data-z-index=\"1\" fill=\"none\" opacity=\"1\" stroke=\"#e6e6e6\" stroke-dasharray=\"none\" stroke-width=\"1\"><\/path><path class=\"highcharts-grid-line\" d=\"M 39 170.5 L 499 170.5\" data-z-index=\"1\" fill=\"none\" opacity=\"1\" stroke=\"#e6e6e6\" stroke-dasharray=\"none\" stroke-width=\"1\"><\/path><path class=\"highcharts-grid-line\" d=\"M 39 131.5 L 499 131.5\" data-z-index=\"1\" fill=\"none\" opacity=\"1\" stroke=\"#e6e6e6\" stroke-dasharray=\"none\" stroke-width=\"1\"><\/path><path class=\"highcharts-grid-line\" d=\"M 39 91.5 L 499 91.5\" data-z-index=\"1\" fill=\"none\" opacity=\"1\" stroke=\"#e6e6e6\" stroke-dasharray=\"none\" stroke-width=\"1\"><\/path><\/g><rect aria-hidden=\"true\" class=\"highcharts-plot-border\" data-z-index=\"1\" fill=\"none\" height=\"233\" width=\"460\" x=\"39\" y=\"92\"><\/rect><g aria-hidden=\"true\" class=\"highcharts-axis highcharts-xaxis\" data-z-index=\"2\"><path class=\"highcharts-axis-line\" d=\"M 39 325.5 L 499 325.5\" data-z-index=\"7\" fill=\"none\" stroke=\"#ccd6eb\" stroke-width=\"1\"><\/path><\/g><g aria-hidden=\"true\" class=\"highcharts-axis highcharts-yaxis\" data-z-index=\"2\"><path class=\"highcharts-axis-line\" d=\"M 39 92 L 39 325\" data-z-index=\"7\" fill=\"none\"><\/path><\/g><g aria-hidden=\"false\" class=\"highcharts-series-group\" data-z-index=\"3\"><g aria-hidden=\"false\" aria-label=\"\" class=\"highcharts-series highcharts-series-0 highcharts-column-series highcharts-color-0\" clip-path=\"url(#highcharts-p5dnaau-501-)\" data-z-index=\"0.1\" opacity=\"1\" transform=\"translate(39,92) scale(1 1)\"><rect aria-label=\"1. 7MM, 10.1. Numbers in Million.\" class=\"highcharts-point highcharts-color-0\" fill=\"#7cb5ec\" height=\"196\" opacity=\"1\" role=\"img\" stroke=\"#ffffff\" stroke-width=\"1\" style=\"outline: none;\" tabindex=\"-1\" width=\"56\" x=\"29.5\" y=\"37.5\"><\/rect><rect aria-label=\"2. US, 3.2. Numbers in Million.\" class=\"highcharts-point highcharts-color-0\" fill=\"#7cb5ec\" height=\"62\" opacity=\"1\" role=\"img\" stroke=\"#ffffff\" stroke-width=\"1\" style=\"outline: none;\" tabindex=\"-1\" width=\"56\" x=\"144.5\" y=\"171.5\"><\/rect><rect aria-label=\"3. Germany, 1. Numbers in Million.\" class=\"highcharts-point highcharts-color-0\" fill=\"#7cb5ec\" height=\"19\" opacity=\"1\" role=\"img\" stroke=\"#ffffff\" stroke-width=\"1\" style=\"outline: none;\" tabindex=\"-1\" width=\"56\" x=\"259.5\" y=\"214.5\"><\/rect><rect aria-label=\"4. Japan, 2.8. Numbers in Million.\" class=\"highcharts-point highcharts-color-0\" fill=\"#7cb5ec\" height=\"54\" opacity=\"1\" role=\"img\" stroke=\"#ffffff\" stroke-width=\"1\" style=\"outline: none;\" tabindex=\"-1\" width=\"56\" x=\"374.5\" y=\"179.5\"><\/rect><\/g><g aria-hidden=\"true\" class=\"highcharts-markers highcharts-series-0 highcharts-column-series highcharts-color-0\" clip-path=\"none\" data-z-index=\"0.1\" opacity=\"1\" transform=\"translate(39,92) scale(1 1)\"><\/g><\/g><text aria-hidden=\"true\" class=\"highcharts-title\" data-z-index=\"4\" style=\"color: rgb(51, 51, 51); font-size: 18px; fill: rgb(51, 51, 51);\" text-anchor=\"middle\" x=\"255\" y=\"24\">Glaucoma Diagnosed Prevalent Population (in<tspan dy=\"21\" x=\"255\">\u200b<\/tspan>2020)<\/text><text aria-hidden=\"true\" class=\"highcharts-subtitle\" data-z-index=\"4\" style=\"color: rgb(102, 102, 102); fill: rgb(102, 102, 102);\" text-anchor=\"middle\" x=\"255\" y=\"73\">Glaucoma Epidemiology Forecast &#8211; 2030<\/text><text aria-hidden=\"true\" class=\"highcharts-caption\" data-z-index=\"4\" style=\"color: rgb(102, 102, 102); fill: rgb(102, 102, 102);\" text-anchor=\"start\" x=\"10\" y=\"397\"><\/text><g aria-hidden=\"true\" class=\"highcharts-legend highcharts-no-tooltip\" data-z-index=\"7\" transform=\"translate(181,359)\"><rect class=\"highcharts-legend-box\" fill=\"none\" height=\"26\" rx=\"0\" ry=\"0\" visibility=\"visible\" width=\"147\" x=\"0\" y=\"0\"><\/rect><g data-z-index=\"1\"><g><g class=\"highcharts-legend-item highcharts-column-series highcharts-color-0 highcharts-series-0\" data-z-index=\"1\" transform=\"translate(8,3)\"><text data-z-index=\"2\" style=\"color: rgb(51, 51, 51); cursor: pointer; font-size: 12px; font-weight: bold; fill: rgb(51, 51, 51);\" text-anchor=\"start\" x=\"21\" y=\"15\">Numbers in Million<\/text><rect class=\"highcharts-point\" data-z-index=\"3\" fill=\"#7cb5ec\" height=\"12\" rx=\"6\" ry=\"6\" width=\"12\" x=\"2\" y=\"4\"><\/rect><\/g><\/g><\/g><\/g><g aria-hidden=\"true\" class=\"highcharts-axis-labels highcharts-xaxis-labels\" data-z-index=\"7\"><text opacity=\"1\" style=\"color: rgb(102, 102, 102); cursor: default; font-size: 11px; fill: rgb(102, 102, 102);\" text-anchor=\"middle\" transform=\"translate(0,0)\" x=\"96.5\" y=\"344\">7MM<\/text><text opacity=\"1\" style=\"color: rgb(102, 102, 102); cursor: default; font-size: 11px; fill: rgb(102, 102, 102);\" text-anchor=\"middle\" transform=\"translate(0,0)\" x=\"211.5\" y=\"344\">US<\/text><text opacity=\"1\" style=\"color: rgb(102, 102, 102); cursor: default; font-size: 11px; fill: rgb(102, 102, 102);\" text-anchor=\"middle\" transform=\"translate(0,0)\" x=\"326.5\" y=\"344\">Germany<\/text><text opacity=\"1\" style=\"color: rgb(102, 102, 102); cursor: default; font-size: 11px; fill: rgb(102, 102, 102);\" text-anchor=\"middle\" transform=\"translate(0,0)\" x=\"441.5\" y=\"344\">Japan<\/text><\/g><g aria-hidden=\"true\" class=\"highcharts-axis-labels highcharts-yaxis-labels\" data-z-index=\"7\"><text opacity=\"1\" style=\"color: rgb(102, 102, 102); cursor: default; font-size: 11px; fill: rgb(102, 102, 102);\" text-anchor=\"end\" transform=\"translate(0,0)\" x=\"24\" y=\"329\">0<\/text><text opacity=\"1\" style=\"color: rgb(102, 102, 102); cursor: default; font-size: 11px; fill: rgb(102, 102, 102);\" text-anchor=\"end\" transform=\"translate(0,0)\" x=\"24\" y=\"290\">2<\/text><text opacity=\"1\" style=\"color: rgb(102, 102, 102); cursor: default; font-size: 11px; fill: rgb(102, 102, 102);\" text-anchor=\"end\" transform=\"translate(0,0)\" x=\"24\" y=\"251\">4<\/text><text opacity=\"1\" style=\"color: rgb(102, 102, 102); cursor: default; font-size: 11px; fill: rgb(102, 102, 102);\" text-anchor=\"end\" transform=\"translate(0,0)\" x=\"24\" y=\"213\">6<\/text><text opacity=\"1\" style=\"color: rgb(102, 102, 102); cursor: default; font-size: 11px; fill: rgb(102, 102, 102);\" text-anchor=\"end\" transform=\"translate(0,0)\" x=\"24\" y=\"174\">8<\/text><text opacity=\"1\" style=\"color: rgb(102, 102, 102); cursor: default; font-size: 11px; fill: rgb(102, 102, 102);\" text-anchor=\"end\" transform=\"translate(0,0)\" x=\"24\" y=\"135\">10<\/text><text opacity=\"1\" style=\"color: rgb(102, 102, 102); cursor: default; font-size: 11px; fill: rgb(102, 102, 102);\" text-anchor=\"end\" transform=\"translate(0,0)\" x=\"24\" y=\"96\">12<\/text><\/g><text aria-hidden=\"false\" aria-label=\"Chart credits: Glaucoma Epidemiology Forecast - 2030\" class=\"highcharts-credits\" data-z-index=\"8\" style=\"cursor: pointer; color: rgb(153, 153, 153); font-size: 9px; fill: rgb(153, 153, 153);\" text-anchor=\"end\" x=\"499\" y=\"395\">Glaucoma Epidemiology Forecast &#8211; 2030<\/text><g aria-hidden=\"true\" class=\"highcharts-control-points\" clip-path=\"url(#highcharts-p5dnaau-502-)\" data-z-index=\"99\"><\/g><\/svg><\/div><script>(function(){ var files = [\"https:\/\/code.highcharts.com\/stock\/highstock.js\",\"https:\/\/code.highcharts.com\/highcharts-more.js\",\"https:\/\/code.highcharts.com\/highcharts-3d.js\",\"https:\/\/code.highcharts.com\/modules\/data.js\",\"https:\/\/code.highcharts.com\/modules\/exporting.js\",\"https:\/\/code.highcharts.com\/modules\/funnel.js\",\"https:\/\/code.highcharts.com\/modules\/annotations.js\",\"https:\/\/code.highcharts.com\/modules\/accessibility.js\",\"https:\/\/code.highcharts.com\/modules\/solid-gauge.js\"],loaded = 0; if (typeof window[\"HighchartsEditor\"] === \"undefined\") {window.HighchartsEditor = {ondone: [cl],hasWrapped: false,hasLoaded: false};include(files[0]);} else {if (window.HighchartsEditor.hasLoaded) {cl();} else {window.HighchartsEditor.ondone.push(cl);}}function isScriptAlreadyIncluded(src){var scripts = document.getElementsByTagName(\"script\");for (var i = 0; i < scripts.length; i++) {if (scripts[i].hasAttribute(\"src\")) {if ((scripts[i].getAttribute(\"src\") || \"\").indexOf(src) >= 0 || (scripts[i].getAttribute(\"src\") === \"http:\/\/code.highcharts.com\/highcharts.js\" && src === \"https:\/\/code.highcharts.com\/stock\/highstock.js\")) {return true;}}}return false;}function check() {if (loaded === files.length) {for (var i = 0; i < window.HighchartsEditor.ondone.length; i++) {try {window.HighchartsEditor.ondone[i]();} catch(e) {console.error(e);}}window.HighchartsEditor.hasLoaded = true;}}function include(script) {function next() {++loaded;if (loaded < files.length) {include(files[loaded]);}check();}if (isScriptAlreadyIncluded(script)) {return next();}var sc=document.createElement(\"script\");sc.src = script;sc.type=\"text\/javascript\";sc.onload=function() { next(); };document.head.appendChild(sc);}function each(a, fn){if (typeof a.forEach !== \"undefined\"){a.forEach(fn);}else{for (var i = 0; i < a.length; i++){if (fn) {fn(a[i]);}}}}var inc = {},incl=[]; each(document.querySelectorAll(\"script\"), function(t) {inc[t.src.substr(0, t.src.indexOf(\"?\"))] = 1; }); function cl() {if(typeof window[\"Highcharts\"] !== \"undefined\"){var options={\"title\":{\"text\":\"Glaucoma Diagnosed Prevalent Population (in 2020)\"},\"subtitle\":{\"text\":\"Glaucoma Epidemiology Forecast - 2030\"},\"exporting\":{},\"chart\":{\"type\":\"column\"},\"series[0]\":{\"type\":\"line\"},\"series\":[{\"name\":\"Numbers in Million\",\"turboThreshold\":0}],\"plotOptions\":{\"series\":{\"animation\":false}},\"data\":{\"csv\":\"\\\"Column 1\\\";\\\"Numbers in Million\\\"\\n\\\"7MM\\\";10.1\\n\\\"US\\\";3.2\\n\\\"Germany\\\";1\\n\\\"Japan\\\";2.8\",\"googleSpreadsheetKey\":false,\"googleSpreadsheetWorksheet\":false},\"yAxis\":[{\"title\":{\"text\":\"\"}}],\"credits\":{\"href\":\"https:\/\/www.delveinsight.com\/report-store\/glaucoma-epidemiology-forecast-insight\",\"text\":\"Glaucoma Epidemiology Forecast - 2030\"}};\/*\/\/ Sample of extending options:Highcharts.merge(true, options, {    chart: {        backgroundColor: \"#bada55\"    },    plotOptions: {        series: {            cursor: \"pointer\",            events: {                click: function(event) {                    alert(this.name + \" clicked\\n\" +                          \"Alt: \" + event.altKey + \"\\n\" +                          \"Control: \" + event.ctrlKey + \"\\n\" +                          \"Shift: \" + event.shiftKey + \"\\n\");                }            }        }    }});*\/new Highcharts.Chart(\"highcharts-632814c1-f355-43e0-9495-0fe28c044ef9\", options);}}})();<\/script><\/div><p>&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Furthermore, escalating aging population is also expected to contribute to the Glaucoma Drainage Devices market growth. This is because older age is not only a risk factor for developing glaucoma but also aids its progression. Various studies have demonstrated that the percentage of glaucoma patients dramatically increases with age. As per the <strong>World Population Ageing 2020<\/strong> highlights published by <strong>the United Nations in the year 2020<\/strong>, about <strong>727 million<\/strong> people aged 65 years and above across the globe which is projected to increase to over <strong>1.5 billion<\/strong> by the year 2050. Thus, the rising old age population could potentially increase the likelihood of glaucoma among them thereby raising the demand for glaucoma drainage devices.<\/li>\n\n\n\n<li>In addition, the rising prevalence of lifestyle-associated disorders such as <a href=\"https:\/\/www.delveinsight.com\/blog\/diabetes-types-risk-factors-and-treatment-options\">diabetes<\/a> and hypertension among the population could augment the market for these devices as various studies have shown that an increase in diabetes or <a href=\"https:\/\/www.delveinsight.com\/blog\/pulmonary-arterial-hypertension-therapies\">hypertension<\/a> elevates the risk of developing glaucoma by many folds. According to the <strong>International Diabetes Federation (IDF) 2021<\/strong> data, an estimated <strong>537 million<\/strong> adults (20-79 years) were living with diabetes in the same year, and the number is projected to increase to <strong>643 <\/strong>million by 2030 and <strong>783 million<\/strong> by 2045. Additionally, as per the same source mentioned in the year 2020, an estimated <strong>191 million<\/strong> people living with diabetes are estimated to develop diabetic retinopathy by 2030.\u00a0<\/li>\n<\/ul>\n\n\n\n<p>Moreover, the technological innovation in product development in glaucoma drainage devices will lead to an increase in the demand for these devices, thereby leading to the Glaucoma Drainage Devices market growth. For instance, in August 2019, New World Medical launched the newest addition to the company's trusted Ahmed\u00ae brand of drainage devices, <strong>\u201cAhmed ClearPath glaucoma drainage device\u201d<\/strong>. One of the unique features of the Ahmed ClearPath implant is a flexible plate with a contour that closely conforms to the curvature of the eye. Therefore, such advancement might lead to an increase in the adoption of these devices and thus contributing to the market growth.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Key_Five_Players_in_the_Glaucoma_Drainage_Devices_Market\"><\/span><strong>Key Five Players in the Glaucoma Drainage Devices Market<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>The Glaucoma Drainage Devices market is dominated by a few of the key manufacturers. Also, there exists a predominant competition between the market players regarding the development and marketing of new products. Currently, the Glaucoma companies are actively involved in newer and innovative methods for addressing certain post-operational surgical complications.<\/p>\n\n\n\n<p>As per Delveinsight analysis in the report titled <strong>\u201c<\/strong><a href=\"https:\/\/www.delveinsight.com\/report-store\/glaucoma-drainage-devices-market\"><strong>Glaucoma Drainage Devices Market Insight Report<\/strong><\/a><strong>\u201d<\/strong>, the global key players in the market are as follows:<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img decoding=\"async\" width=\"850\" height=\"293\" src=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/04\/15133827\/Key-Companies-in-the-Glaucoma-Drainage-Devices-Market.png\" alt=\"Key Companies in the Glaucoma Drainage Devices Market\" class=\"wp-image-17036\" srcset=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/04\/15133827\/Key-Companies-in-the-Glaucoma-Drainage-Devices-Market.png 850w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/04\/15133827\/Key-Companies-in-the-Glaucoma-Drainage-Devices-Market-300x103.png 300w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/04\/15133827\/Key-Companies-in-the-Glaucoma-Drainage-Devices-Market-150x52.png 150w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/04\/15133827\/Key-Companies-in-the-Glaucoma-Drainage-Devices-Market-768x265.png 768w\" sizes=\"(max-width: 850px) 100vw, 850px\" \/><figcaption class=\"wp-element-caption\"><strong>Leading Companies Dominating the Glaucoma Drainage Devices Market<\/strong><\/figcaption><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Johnson_Johnson_Services_Inc_%E2%80%93_New_Jersey_United_States\"><\/span><strong>Johnson &amp; Johnson Services, Inc. \u2013 New Jersey, United States<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Johnson &amp; Johnson Vision, a subsidiary of Johnson &amp; Johnson Services, Inc. was established in the year 1996. The division is a part of the medical devices division of the parent company is dedicated to providing products ophthalmology-specific products ranging from surgical systems to contact lenses to <a href=\"https:\/\/www.delveinsight.com\/report-store\/intraocular-lens-market\">intraocular lenses<\/a>, glaucoma, and other implants.<strong>BAERVELDT\u00ae Glaucoma Implants <\/strong>are the key glaucoma drainage device in the company\u2019s product portfolio.<\/p>\n\n\n\n<div class=\"visualizer-front-container visualizer-lazy-render\" id=\"chart_wrapper_visualizer-17022-1677468166\"><style type=\"text\/css\" name=\"visualizer-custom-css\" id=\"customcss-visualizer-17022\">.locker,.locker-loader{position:absolute;top:0;left:0;width:100%;height:100%}.locker{z-index:1000;opacity:.8;background-color:#fff;-ms-filter:\"progid:DXImageTransform.Microsoft.Alpha(Opacity=80)\";filter:alpha(opacity=80)}.locker-loader{z-index:1001;background:url(https:\/\/www.delveinsight.com\/blog\/wp-content\/plugins\/visualizer\/images\/ajax-loader.gif) no-repeat center center}.dt-button{display:none!important}.visualizer-front-container.visualizer-lazy-render{content-visibility: auto;}.google-visualization-controls-categoryfilter label.google-visualization-controls-label {vertical-align: middle;}.google-visualization-controls-categoryfilter li.goog-inline-block {margin: 0 0.2em;}.google-visualization-controls-categoryfilter li {padding: 0 0.2em;}.visualizer-front-container .dataTables_scrollHeadInner{margin: 0 auto;}<\/style><div id=\"visualizer-17022-1677468166\" class=\"visualizer-front  visualizer-front-17022\"><\/div><!-- Not showing structured data for chart 17022 because title is empty --><\/div>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Alcon_Inc_-_Illinois_United_States\"><\/span><strong>Alcon Inc - Illinois, United States<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>With a 70-plus year heritage, Alcon is one of the largest eye care device companies in the world, dedicated to helping people see brilliantly since 1931. The company has the widest array of eye care offerings in the industry with products organized into two businesses: Surgical and Vision Care for the management of cataracts and refractive errors, like presbyopia and astigmatism, and ocular disease like dry eye, ocular allergies, among others.The company has <strong>EX-PRESS Glaucoma Filtration Device <\/strong>in its product portfolio<strong> <\/strong>for the <a href=\"https:\/\/www.delveinsight.com\/report-store\/glaucoma-market-insight\">treatment of glaucoma<\/a>.<\/p>\n\n\n\n<div class=\"visualizer-front-container visualizer-lazy-render\" id=\"chart_wrapper_visualizer-17024-1691479578\"><style type=\"text\/css\" name=\"visualizer-custom-css\" id=\"customcss-visualizer-17024\">.locker,.locker-loader{position:absolute;top:0;left:0;width:100%;height:100%}.locker{z-index:1000;opacity:.8;background-color:#fff;-ms-filter:\"progid:DXImageTransform.Microsoft.Alpha(Opacity=80)\";filter:alpha(opacity=80)}.locker-loader{z-index:1001;background:url(https:\/\/www.delveinsight.com\/blog\/wp-content\/plugins\/visualizer\/images\/ajax-loader.gif) no-repeat center center}.dt-button{display:none!important}.visualizer-front-container.visualizer-lazy-render{content-visibility: auto;}.google-visualization-controls-categoryfilter label.google-visualization-controls-label {vertical-align: middle;}.google-visualization-controls-categoryfilter li.goog-inline-block {margin: 0 0.2em;}.google-visualization-controls-categoryfilter li {padding: 0 0.2em;}.visualizer-front-container .dataTables_scrollHeadInner{margin: 0 auto;}<\/style><div id=\"visualizer-17024-1691479578\" class=\"visualizer-front  visualizer-front-17024\"><\/div><!-- Not showing structured data for chart 17024 because title is empty --><\/div>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Glaukos_Corporation_-_California_United_States\"><\/span><strong>Glaukos Corporation - California, United States<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Glaukos Corporation, founded in the year 1998, is a medical technology and pharmaceutical company primarily developing new therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. The company is the pioneer in launching the Micro-Invasive Glaucoma Surgery (MIGS) based devices in the market for treating glaucoma. In 2012, the company launched its first MIGS device\u2014the iStent\u00ae\u2014in the United States, followed by other next-generation iStent inject\u00ae device in September 2018 and iStent inject\u00ae W in September 2020.<\/p>\n\n\n\n<p>The product portfolio of the company is as follows:<\/p>\n\n\n\n<div class=\"visualizer-front-container visualizer-lazy-render\" id=\"chart_wrapper_visualizer-17026-684130095\"><style type=\"text\/css\" name=\"visualizer-custom-css\" id=\"customcss-visualizer-17026\">.locker,.locker-loader{position:absolute;top:0;left:0;width:100%;height:100%}.locker{z-index:1000;opacity:.8;background-color:#fff;-ms-filter:\"progid:DXImageTransform.Microsoft.Alpha(Opacity=80)\";filter:alpha(opacity=80)}.locker-loader{z-index:1001;background:url(https:\/\/www.delveinsight.com\/blog\/wp-content\/plugins\/visualizer\/images\/ajax-loader.gif) no-repeat center center}.dt-button{display:none!important}.visualizer-front-container.visualizer-lazy-render{content-visibility: auto;}.google-visualization-controls-categoryfilter label.google-visualization-controls-label {vertical-align: middle;}.google-visualization-controls-categoryfilter li.goog-inline-block {margin: 0 0.2em;}.google-visualization-controls-categoryfilter li {padding: 0 0.2em;}.visualizer-front-container .dataTables_scrollHeadInner{margin: 0 auto;}<\/style><div id=\"visualizer-17026-684130095\" class=\"visualizer-front  visualizer-front-17026\"><\/div><!-- Not showing structured data for chart 17026 because title is empty --><\/div>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"AbbVie_Inc_-_Illinois_United_States\"><\/span><strong>AbbVie Inc. - Illinois, United States<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Allergan, now a part of AbbVie Inc., markets a portfolio of leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women's health, urology, and anti-infective therapeutic categories. The company has<strong> XEN\u00ae Gel Stent<\/strong>, the only FDA-cleared stent that creates a low-lying, ab interno bleb for effective intraocular pressure (IOP) reduction.<\/p>\n\n\n\n<div class=\"visualizer-front-container visualizer-lazy-render\" id=\"chart_wrapper_visualizer-17028-708670732\"><style type=\"text\/css\" name=\"visualizer-custom-css\" id=\"customcss-visualizer-17028\">.locker,.locker-loader{position:absolute;top:0;left:0;width:100%;height:100%}.locker{z-index:1000;opacity:.8;background-color:#fff;-ms-filter:\"progid:DXImageTransform.Microsoft.Alpha(Opacity=80)\";filter:alpha(opacity=80)}.locker-loader{z-index:1001;background:url(https:\/\/www.delveinsight.com\/blog\/wp-content\/plugins\/visualizer\/images\/ajax-loader.gif) no-repeat center center}.dt-button{display:none!important}.visualizer-front-container.visualizer-lazy-render{content-visibility: auto;}.google-visualization-controls-categoryfilter label.google-visualization-controls-label {vertical-align: middle;}.google-visualization-controls-categoryfilter li.goog-inline-block {margin: 0 0.2em;}.google-visualization-controls-categoryfilter li {padding: 0 0.2em;}.visualizer-front-container .dataTables_scrollHeadInner{margin: 0 auto;}<\/style><div id=\"visualizer-17028-708670732\" class=\"visualizer-front  visualizer-front-17028\"><\/div><!-- Not showing structured data for chart 17028 because title is empty --><\/div>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Santen_Pharmaceutical_Co_Ltd_%E2%80%93_Osaka_Japan\"><\/span><strong>Santen Pharmaceutical Co., Ltd \u2013 Osaka, Japan<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Santen Pharmaceutical Co., Ltd., established in the year 1980 is growing into a leading ophthalmic pharmaceutical company by selling its eye care products in more than 60 countries. The company collaborates closely with ophthalmic medical professionals for the development of innovative solutions and the advancement of the ophthalmic ecosystem.The company has <strong>PRESERFLO MicroShunt<\/strong> in its product arena for the treatment of glaucoma.<\/p>\n\n\n\n<div class=\"visualizer-front-container visualizer-lazy-render\" id=\"chart_wrapper_visualizer-17032-73931551\"><style type=\"text\/css\" name=\"visualizer-custom-css\" id=\"customcss-visualizer-17032\">.locker,.locker-loader{position:absolute;top:0;left:0;width:100%;height:100%}.locker{z-index:1000;opacity:.8;background-color:#fff;-ms-filter:\"progid:DXImageTransform.Microsoft.Alpha(Opacity=80)\";filter:alpha(opacity=80)}.locker-loader{z-index:1001;background:url(https:\/\/www.delveinsight.com\/blog\/wp-content\/plugins\/visualizer\/images\/ajax-loader.gif) no-repeat center center}.dt-button{display:none!important}.visualizer-front-container.visualizer-lazy-render{content-visibility: auto;}.google-visualization-controls-categoryfilter label.google-visualization-controls-label {vertical-align: middle;}.google-visualization-controls-categoryfilter li.goog-inline-block {margin: 0 0.2em;}.google-visualization-controls-categoryfilter li {padding: 0 0.2em;}.visualizer-front-container .dataTables_scrollHeadInner{margin: 0 auto;}<\/style><div id=\"visualizer-17032-73931551\" class=\"visualizer-front  visualizer-front-17032\"><\/div><!-- Not showing structured data for chart 17032 because title is empty --><\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Developments_in_the_Glaucoma_Drainage_Devices_Market\"><\/span><strong>Recent Developments in the Glaucoma Drainage Devices Market<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>In <strong>February 2022<\/strong>, <strong>Santen Pharmaceutical Co., Ltd<\/strong>. was granted the marketing authorization for the <strong>PRESERFLO MicroShunt Glaucoma Drainage System Core Kit<\/strong>, an intraocular drainage device.<\/li>\n\n\n\n<li>In <strong>May 2021<\/strong>, <strong>Glaukos Corporation<\/strong> entered into a new development and commercialization license agreement with <strong>Santen Pharmaceutical Co., Ltd. (Santen)<\/strong> for the <strong>PRESERFLO\u2122 MicroShunt<\/strong> (development code: DE-128). The former company has also obtained exclusive commercialization rights for the MicroShunt in the United States, Australia, New Zealand, Canada, Brazil, Mexico, and the remainder of Latin America.<\/li>\n\n\n\n<li>In <strong>April 2020<\/strong>, <strong>Allergan Plc.,<\/strong> now a subsidiary of <strong>AbbVie Inc.,<\/strong> received product approval from <strong>China's National Medical Products Administration (NMPA)<\/strong> for <strong>XEN\u00ae Gel Stent<\/strong> for the surgical management of patients with refractory glaucoma through the Real World Evidence pathway.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Owing to the presence of some global and regional players worldwide, the Glaucoma Drainage Devices market is moderately competitive. The key Glaucoma companies offer a wide range of glaucoma drainage implants based on different technologies. Key players employed various strategic business activities such as partnerships, product launches, mergers, and acquisitions to hold their market position.<\/p>\n\n\n\n<p>As per DelveInsight\u2019s assumption the <a href=\"https:\/\/www.delveinsight.com\/report-store\/glaucoma-drainage-devices-market\">global Glaucoma Drainage Devices market<\/a> is expected to rise at a constant growth rate during the forecasted period owing to the rise in the target population, the availability of a conducive environment for product development and launches, increase in strategic business activities by the key manufacturers for developing technologically advanced and innovative products, rise in product approvals, among others. For instance, in September 2021, <strong>Glaukos Corporation<\/strong> submitted a supplemental premarket approval application to the <strong>US Food and Drug Administration (FDA)<\/strong> for its <strong>iStent infinite Trabecular Micro-Bypass System<\/strong>. Additionally, an increase in programs to raise awareness regarding glaucoma management could also increase the adoption of glaucoma drainage implants. For instance, <strong>Santen Pharmaceuticals Ltd<\/strong>., along with a group of patient advocacy groups across Europe, is leading a multi-channel awareness campaign to encourage patients to prioritize their glaucoma during the pandemic. The first phase of activities reached millions of patients in France and other European countries through national and regional newspapers as well as through various digital channels.<\/p>\n\n\n\n<p>In addition, budding stage companies investing in the development of advanced glaucoma drainage devices such as <strong>MicroOptx, AVISI TECHNOLOGIES INC<\/strong>., among others will also surge the market. For instance, <strong>Avisi Technologies Inc. <\/strong>is developing a next-generation aqueous shunt, <strong>VisiPlate<\/strong>,&nbsp; that aims to treat glaucoma. It leverages an ultrathin nanoplate that is designed to achieve unprecedented strength and flexibility for its scale. VisiPlate is 20x thinner than human hair. It has a unique multichannel design to create outflow redundancy, which may lead to sustained IOP control over time. The device is made of alumina and parylene-c, non-fibrotic materials that have the potential to reduce the risk of scarring and blockage. In September 2020, <strong>Avisi Technologies<\/strong> received a USD 1 million Small Business Innovation Research Phase II grant from the National Science Foundation (NSF) for preclinical work.<\/p>\n\n\n\n<p>However, a few complications of glaucoma drainage devices are infection, conjunctival erosion, and others that are likely to impede the Glaucoma Drainage Devices market.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large is-resized\"><a href=\"https:\/\/www.delveinsight.com\/report-store\/glaucoma-drainage-devices-market\"><img decoding=\"async\" width=\"1024\" height=\"256\" src=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/04\/15133708\/Glaucoma-Drainage-Devices-Market-1024x256.png\" alt=\"Glaucoma Drainage Devices Market\" class=\"wp-image-17035\" style=\"width:1024px;height:256px\" srcset=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/04\/15133708\/Glaucoma-Drainage-Devices-Market-1024x256.png 1024w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/04\/15133708\/Glaucoma-Drainage-Devices-Market-300x75.png 300w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/04\/15133708\/Glaucoma-Drainage-Devices-Market-150x38.png 150w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/04\/15133708\/Glaucoma-Drainage-Devices-Market-768x192.png 768w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/04\/15133708\/Glaucoma-Drainage-Devices-Market-1536x384.png 1536w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/04\/15133708\/Glaucoma-Drainage-Devices-Market-1568x392.png 1568w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/04\/15133708\/Glaucoma-Drainage-Devices-Market.png 1584w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/a><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-faqs\"><span class=\"ez-toc-section\" id=\"FAQs\"><\/span>FAQs<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<div class=\"schema-faq wp-block-yoast-faq-block\"><div class=\"schema-faq-section\" id=\"faq-question-1760009468161\"><strong class=\"schema-faq-question\"><strong>What are the different types of glaucoma?<\/strong><\/strong> <p class=\"schema-faq-answer\">Glaucoma is categorized based on the respective structural changes in the anterior segment of the eye. The two major types of glaucoma are Open-angle glaucoma and Angle-closure glaucoma.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1760009476619\"><strong class=\"schema-faq-question\"><strong>What types of glaucoma drainage devices are available?<\/strong><\/strong> <p class=\"schema-faq-answer\">The market offers various types of glaucoma drainage devices, including Conventional aqueous shunts, EX-PRESS\u00ae Glaucoma Filtration Device, and Minimally Invasive Glaucoma Surgery (MIGS) devices.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1760009487674\"><strong class=\"schema-faq-question\"><strong>Who are the prominent players in the glaucoma drainage devices market?<\/strong><\/strong> <p class=\"schema-faq-answer\">The leading glaucoma drainage device companies, such as Johnson &amp; Johnson, AbbVie Inc., Alcon Inc., Glaukos Corporation, Santen Pharmaceutical Co., Ltd, NovaEye Medical Limited, iSTAR Medical SA, Rheon Medical SA, Advanced Ophthalmic Innovations Pte Ltd, New World Medical Inc., Aurolab, and others are currently active in the market.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1760009511701\"><strong class=\"schema-faq-question\"><strong>Where is the glaucoma drainage devices market headed?<\/strong><\/strong> <p class=\"schema-faq-answer\">The global glaucoma drainage devices market was valued at USD 640 million in 2024, growing at a CAGR of ~12% during the forecast period from 2024 to 2030, to reach USD 1.1 billion by 2032.<\/p> <\/div> <\/div>\n","protected":false},"excerpt":{"rendered":"<p>Glaucoma is a group of progressive optic neuropathy which is characterized by the degradation of ganglion cells present in the retina. The loss of the retinal ganglion is associated with intraocular pressure (IOP), an elevated IOP due to an imbalance in the production and drainage of aqueous humor that might lead to structural changes in [&hellip;]<\/p>\n","protected":false},"author":14,"featured_media":17039,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[17],"tags":[2828,19246,19248,19247,7737,7738,7736,19249,19006],"industry":[17226,17225],"therapeutic_areas":[17244],"class_list":["post-17034","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","tag-glaucoma","tag-glaucoma-drainage-devices","tag-glaucoma-drainage-devices-companies","tag-glaucoma-drainage-devices-market","tag-glaucoma-epidemiology","tag-glaucoma-key-companies","tag-glaucoma-therapeutics-market","tag-glaucoma-treatment","tag-open-angle-glaucoma","industry-medical-devices","industry-pharmaceutical","therapeutic_areas-ophthalmology"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.8 (Yoast SEO v25.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Key 5 Companies Working in the Glaucoma Drainage Devices Market<\/title>\n<meta name=\"description\" content=\"The Glaucoma Drainage Devices market is dominated by a few of the key players. Also, there exists a predominant competition between the\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/glaucoma-drainage-devices-market\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Key 5 Companies Working in the Glaucoma Drainage Devices Market\" \/>\n<meta property=\"og:description\" content=\"The Glaucoma Drainage Devices market is dominated by a few of the key players. Also, there exists a predominant competition between the\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/glaucoma-drainage-devices-market\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-04-15T10:17:37+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-09T11:32:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/04\/15134121\/global-glaucoma-drainage-devices-market.png\" \/>\n\t<meta property=\"og:image:width\" content=\"772\" \/>\n\t<meta property=\"og:image:height\" content=\"482\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Sandeep Joshi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sandeep Joshi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"11 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Key 5 Companies Working in the Glaucoma Drainage Devices Market","description":"The Glaucoma Drainage Devices market is dominated by a few of the key players. Also, there exists a predominant competition between the","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/glaucoma-drainage-devices-market","og_locale":"en_US","og_type":"article","og_title":"Key 5 Companies Working in the Glaucoma Drainage Devices Market","og_description":"The Glaucoma Drainage Devices market is dominated by a few of the key players. Also, there exists a predominant competition between the","og_url":"https:\/\/www.delveinsight.com\/blog\/glaucoma-drainage-devices-market","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2022-04-15T10:17:37+00:00","article_modified_time":"2025-10-09T11:32:08+00:00","og_image":[{"width":772,"height":482,"url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/04\/15134121\/global-glaucoma-drainage-devices-market.png","type":"image\/png"}],"author":"Sandeep Joshi","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"Sandeep Joshi","Est. reading time":"11 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":["WebPage","FAQPage"],"@id":"https:\/\/www.delveinsight.com\/blog\/glaucoma-drainage-devices-market","url":"https:\/\/www.delveinsight.com\/blog\/glaucoma-drainage-devices-market","name":"Key 5 Companies Working in the Glaucoma Drainage Devices Market","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.delveinsight.com\/blog\/glaucoma-drainage-devices-market#primaryimage"},"image":{"@id":"https:\/\/www.delveinsight.com\/blog\/glaucoma-drainage-devices-market#primaryimage"},"thumbnailUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/04\/15134121\/global-glaucoma-drainage-devices-market.png","datePublished":"2022-04-15T10:17:37+00:00","dateModified":"2025-10-09T11:32:08+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/f1eefd8dd4afdb0617d6166f8b301e0a"},"description":"The Glaucoma Drainage Devices market is dominated by a few of the key players. Also, there exists a predominant competition between the","mainEntity":[{"@id":"https:\/\/www.delveinsight.com\/blog\/glaucoma-drainage-devices-market#faq-question-1760009468161"},{"@id":"https:\/\/www.delveinsight.com\/blog\/glaucoma-drainage-devices-market#faq-question-1760009476619"},{"@id":"https:\/\/www.delveinsight.com\/blog\/glaucoma-drainage-devices-market#faq-question-1760009487674"},{"@id":"https:\/\/www.delveinsight.com\/blog\/glaucoma-drainage-devices-market#faq-question-1760009511701"}],"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/glaucoma-drainage-devices-market"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/glaucoma-drainage-devices-market#primaryimage","url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/04\/15134121\/global-glaucoma-drainage-devices-market.png","contentUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/04\/15134121\/global-glaucoma-drainage-devices-market.png","width":772,"height":482,"caption":"global-glaucoma-drainage-devices-market"},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/f1eefd8dd4afdb0617d6166f8b301e0a","name":"Sandeep Joshi","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7676451175fe155887a18ffb50e674b270d87436a3fc34ca206f86921cddf4cd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7676451175fe155887a18ffb50e674b270d87436a3fc34ca206f86921cddf4cd?s=96&d=mm&r=g","caption":"Sandeep Joshi"},"sameAs":["http:\/\/Delveinsight.com"]},{"@type":"Question","@id":"https:\/\/www.delveinsight.com\/blog\/glaucoma-drainage-devices-market#faq-question-1760009468161","position":1,"url":"https:\/\/www.delveinsight.com\/blog\/glaucoma-drainage-devices-market#faq-question-1760009468161","name":"What are the different types of glaucoma?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Glaucoma is categorized based on the respective structural changes in the anterior segment of the eye. The two major types of glaucoma are Open-angle glaucoma and Angle-closure glaucoma.","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/www.delveinsight.com\/blog\/glaucoma-drainage-devices-market#faq-question-1760009476619","position":2,"url":"https:\/\/www.delveinsight.com\/blog\/glaucoma-drainage-devices-market#faq-question-1760009476619","name":"What types of glaucoma drainage devices are available?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"The market offers various types of glaucoma drainage devices, including Conventional aqueous shunts, EX-PRESS\u00ae Glaucoma Filtration Device, and Minimally Invasive Glaucoma Surgery (MIGS) devices.","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/www.delveinsight.com\/blog\/glaucoma-drainage-devices-market#faq-question-1760009487674","position":3,"url":"https:\/\/www.delveinsight.com\/blog\/glaucoma-drainage-devices-market#faq-question-1760009487674","name":"Who are the prominent players in the glaucoma drainage devices market?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"The leading glaucoma drainage device companies, such as Johnson &amp; Johnson, AbbVie Inc., Alcon Inc., Glaukos Corporation, Santen Pharmaceutical Co., Ltd, NovaEye Medical Limited, iSTAR Medical SA, Rheon Medical SA, Advanced Ophthalmic Innovations Pte Ltd, New World Medical Inc., Aurolab, and others are currently active in the market.","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/www.delveinsight.com\/blog\/glaucoma-drainage-devices-market#faq-question-1760009511701","position":4,"url":"https:\/\/www.delveinsight.com\/blog\/glaucoma-drainage-devices-market#faq-question-1760009511701","name":"Where is the glaucoma drainage devices market headed?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"The global glaucoma drainage devices market was valued at USD 640 million in 2024, growing at a CAGR of ~12% during the forecast period from 2024 to 2030, to reach USD 1.1 billion by 2032.","inLanguage":"en-US"},"inLanguage":"en-US"}]}},"author_meta":{"display_name":"Sandeep Joshi","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/sjoshidelveinsight-com"},"featured_img":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/04\/15134121\/global-glaucoma-drainage-devices-market-300x187.png","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Articles<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Articles<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">glaucoma<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Glaucoma Drainage Devices<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Glaucoma Drainage Devices Companies<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Glaucoma Drainage Devices Market<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Glaucoma Epidemiology<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Glaucoma Key companies<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Glaucoma therapeutics market<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Glaucoma treatment<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">open-angle glaucoma<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">glaucoma<\/span>","<span class=\"advgb-post-tax-term\">Glaucoma Drainage Devices<\/span>","<span class=\"advgb-post-tax-term\">Glaucoma Drainage Devices Companies<\/span>","<span class=\"advgb-post-tax-term\">Glaucoma Drainage Devices Market<\/span>","<span class=\"advgb-post-tax-term\">Glaucoma Epidemiology<\/span>","<span class=\"advgb-post-tax-term\">Glaucoma Key companies<\/span>","<span class=\"advgb-post-tax-term\">Glaucoma therapeutics market<\/span>","<span class=\"advgb-post-tax-term\">Glaucoma treatment<\/span>","<span class=\"advgb-post-tax-term\">open-angle glaucoma<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 4 years ago","modified":"Updated 6 months ago"},"absolute_dates":{"created":"Posted on Apr 15, 2022","modified":"Updated on Oct 9, 2025"},"absolute_dates_time":{"created":"Posted on Apr 15, 2022 3:47 pm","modified":"Updated on Oct 9, 2025 5:02 pm"},"featured_img_caption":"global-glaucoma-drainage-devices-market","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/17034","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=17034"}],"version-history":[{"count":1,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/17034\/revisions"}],"predecessor-version":[{"id":33637,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/17034\/revisions\/33637"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media\/17039"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=17034"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=17034"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=17034"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=17034"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=17034"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}